Literature DB >> 27900043

Second-look surgery following Hartmann's procedure for obstructive left-sided colorectal cancer.

Naohito Beppu1, Fumihiko Kimura1, Nagahide Matsubara2, Masashi Noda2, Naohiro Tomita2, Hidenori Yanagi1, Naoki Yamanaka1.   

Abstract

The aim of the present study was to investigate the short- and long-term outcomes of patients undergoing second-look surgery following Hartmann's procedure for obstructive left-sided colorectal cancer (LSCC). All patients included in the present study had undergone radical surgery with Hartmann's procedure for obstructive LSCC. Adjuvant chemotherapy was recommended for all patients, and patients with no signs of recurrence following six months of surveillance were planned to undergo second-look surgery. The aim of second-look surgery was early detection of local recurrence and determination of the efficacy of laparoscopic Hartmann procedure reversal. A total of 15 patients with locally advanced colorectal cancer were included in the study. Three patients exhibited peritoneal dissemination at the time of laparoscopic Hartmann procedure reversal and underwent partial peritonectomy. Following adjuvant chemotherapy treatment, laparoscopic Hartmann procedure reversal was performed in all patients. However, two patients underwent colo-anal anastomosis, and two patients underwent right-sided colon or ileum reconstruction. Regarding the oncological outcomes, two of three patients in whom peritoneal dissemination was identified during laparoscopic Hartmann procedure reversal were eventually in remission following the initial surgery and the second-look surgery with partial peritonectomy. Favorable long-term outcomes were observed in 12/15 patients due to no recurrence, which may be due to the surgical techniques used and the timing of the second-look surgery following Hartmann's procedure for the treatment of obstructive LSCC.

Entities:  

Keywords:  Hartmann's procedure; adjuvant chemotherapy; obstructive left-sided colorectal cancer; peritoneal dissemination; second-look surgery

Year:  2016        PMID: 27900043      PMCID: PMC5104057          DOI: 10.3892/ol.2016.5084

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

Review 1.  The management of malignant large bowel obstruction: ACPGBI position statement.

Authors:  P J Finan; S Campbell; R Verma; J MacFie; M Gatt; M C Parker; R Bhardwaj; N R Hall
Journal:  Colorectal Dis       Date:  2007-10       Impact factor: 3.788

Review 2.  Emergency management of malignant acute left-sided colonic obstruction.

Authors:  Vasileios Trompetas
Journal:  Ann R Coll Surg Engl       Date:  2008-04       Impact factor: 1.891

3.  NCCN Clinical Practice Guidelines in Oncology: rectal cancer.

Authors:  Paul F Engstrom; Juan Pablo Arnoletti; Al B Benson; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Anne Covey; Raza A Dilawari; Dayna S Early; Peter C Enzinger; Marwan G Fakih; James Fleshman; Charles Fuchs; Jean L Grem; Krystyna Kiel; James A Knol; Lucille A Leong; Edward Lin; Mary F Mulcahy; Sujata Rao; David P Ryan; Leonard Saltz; David Shibata; John M Skibber; Constantinos Sofocleous; James Thomas; Alan P Venook; Christopher Willett
Journal:  J Natl Compr Canc Netw       Date:  2009-09       Impact factor: 11.908

4.  Single-port access laparoscopic reversal of Hartmann operation.

Authors:  D W Borowski; V Kanakala; A K Agarwal; M A Tabaqchali; D K Garg; T S Gill
Journal:  Dis Colon Rectum       Date:  2011-08       Impact factor: 4.585

5.  Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.

Authors:  S R Pestieau; P H Sugarbaker
Journal:  Dis Colon Rectum       Date:  2000-10       Impact factor: 4.585

6.  A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO).

Authors:  Gary Middleton; Sarah Brown; Catherine Lowe; Timothy Maughan; Stephen Gwyther; Alfred Oliver; Susan Richman; Denise Blake; Vicky Napp; Helen Marshall; Jonathan Wadsley; Nick Maisey; Ian Chau; Mark Hill; Simon Gollins; Sun Myint; Sarah Slater; John Wagstaff; John Bridgewater; Matthew Seymour
Journal:  Eur J Cancer       Date:  2013-08-13       Impact factor: 9.162

7.  Obstructing colonic cancer: failure and survival patterns over a ten-year follow-up after one-stage curative surgery.

Authors:  P G Carraro; M Segala; B M Cesana; G Tiberio
Journal:  Dis Colon Rectum       Date:  2001-02       Impact factor: 4.585

8.  Long-term survival of peritoneal carcinomatosis of colorectal origin.

Authors:  Vic J Verwaal; Serge van Ruth; Arjen Witkamp; Henk Boot; Gooike van Slooten; Frans A N Zoetmulder
Journal:  Ann Surg Oncol       Date:  2004-12-27       Impact factor: 5.344

9.  Obstructing carcinomas of the colon.

Authors:  J W Serpell; F T McDermott; H Katrivessis; E S Hughes
Journal:  Br J Surg       Date:  1989-09       Impact factor: 6.939

10.  Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit.

Authors:  J Mella; A Biffin; A G Radcliffe; J D Stamatakis; R J Steele
Journal:  Br J Surg       Date:  1997-12       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.